April is over, and now, come what May, it’s time for our monthly roundup of news stories highlighting key trends for U.S. drug channels. In this issue:
- My $0.02 on the Cigna/Express Scripts’ $25 insulin program
- Amazon starts marketing PillPack to Prime customers
- Surprise! Magellan drives major biosimilar adoption.
- Prime Therapeutics shows the power of formulary exclusion
Plus, read media coverage of our recent webinar: Preparing for a World Without Rebates.
P.S. Join the more than 7,400 people who follow my daily updates and links to neat stuff at @DrugChannels on Twitter.
Read more »
Source: Post feed
